Italy· 025540030
SUPREFACT*1 siringa SC 6,3 mg rilascio prolungato
A buserelin product containing buserelin, registered in Italy by CHEPLAPHARM ARZNEIMITTEL GMBH, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Buserelin is registered in 8 of 19 countries.
Countries holding a registration under ATC L02AE01 (buserelin), each read from that country’s own register.
- This record: Italy
- 4 of them publish a price we can compare per daily dose
Buserelin · ATC L02AE01
8 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Netherlands
- United Kingdom
The record
At a glance
- Active substance
- Buserelin
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL GMBH
- Country
- Italy (IT)
- ATC code
- L02AE01
- ATC class
- Buserelin
- Defined daily dose
- 0.11 mg, Implantat
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic025540030SUPREFACT*1 siringa SC 6,3 mg rilascio prolungatoEUR 323.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Buserelin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBusol vetaniMedica GmbH
- United KingdomBuserelin 5.5mg/5.5ml solution for injection vialsNeon Healthcare Ltd
- SwedenSuprecur 0,15 mg/dos Nässpray, lösningCheplapharm Arzneimittel GmbH
- SpainSUPREFACT 1 mg/ml SOLUCION INYECTABLECheplapharm Arzneimittel Gmbh
- GermanyMetrelefCheplapharm Arzneimittel Gmbh
- NetherlandsSuprefact Depot 3 maanden, implantatiestift 9,45 mgCHEPLAPHARM Arzneimittel GmbH
- CanadaSUPREFACTCHEPLAPHARM ARZNEIMITTEL GMBH
- BelgiumSuprefact Nasal 0.1 mgSanofi Belgium
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Suprecur, Suprefact
- Bulgaria · Супрефакт Депо 3 Месеца
- Germany · Profact Depot, Profact Pro Injectione
- Spain · Suprefact, Suprefact Depot
- United Kingdom (Northern Ireland) · Buserelin, Suprecur Injection
- Greece · Suprefact Depot 3 Μήνεσ
- Hungary · Suprefact
- Netherlands · Suprefact Depot
- Sweden · Suprecur, Suprefact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f90372b9-a611-477f-9eb6-6f84a94e356f GET /v1/drugs/f90372b9-a611-477f-9eb6-6f84a94e356f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 323.5,
"source": "aifa",
"currency": "EUR",
"strength": "BUSERELIN 6,3MG 1 UNITA' USO PARENTERALE RP",
"substance": "Buserelin",
"equivalence_group": "IJC",
"transparency_flag": null
}See everything about buserelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.